MURRAYFIELD MEDICAL LIMITED
Opportunity 71/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-04-30 | 2024-04-30 |
|---|---|---|
| Average employees | 0 | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (6 events)Click to expand
- 2025-12-24📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-11📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-09-08📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2022-04-20🏢Company incorporatedAs MURRAYFIELD MEDICAL LIMITED
- 2022-04-20➕DONALDSON GREWAR, Lorna, Dr appointeddirector
- 2022-04-20📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Sole director: Only one active director — all governance concentrated on one person.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Lorna Donaldson Grewar Individual · British · DOB 10/1974 · age 52 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 20/04/2022 |
Mr Michael Grewar Individual · British · DOB 10/1976 · age 50 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 20/04/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · KY postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| MONKEY MIND RELAXATION LTD→ SC681060 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ONYX COACHING & HEALTH LTD→ SC793048 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| PEAK PHYSIQUE WELLNESS LTD→ SC882817 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| PILLAI RADIOLOGY LTD→ SC626916 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| PRO EQUILIBRIUM LTD→ SC704075 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| PUREGIRE LIMITED→ SC866432 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| R MITEVA & ASSOCIATES LIMITED→ SC379836 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| RACH OPTOMETRISTS LTD→ SC625592 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| RB INVEST LTD→ SC752443 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| REDPATH'S MASSAGE THERAPY LTD→ SC407317 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| REGENCY MEDICINE LTD.→ SC189762 · est 1998 · no financials extracted | — | — | — | — | 27y | — | — |
| RESIDENCE CARE GROUP→ SC842671 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.